Editorial: Extending upadacitinib induction dosing in ulcerative colitis-A delicate balance of efficacy and safety. Author's reply. Panaccione R. Aliment Pharmacol Ther 2024;59:581-582.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Panaccione R. Editorial: Extending upadacitinib induction dosing in ulcerative colitis-A delicate balance of efficacy and safety. Author's reply. Aliment Pharmacol Ther 2024;59:581-582.
PMID: 38247143